A detailed history of Pensionmark Financial Group, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Pensionmark Financial Group, LLC holds 7,798 shares of CTLT stock, worth $460,082. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,798
Previous 8,208 5.0%
Holding current value
$460,082
Previous $461,000 2.39%
% of portfolio
0.0%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.16 - $60.96 $23,025 - $24,993
-410 Reduced 5.0%
7,798 $472,000
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $439,784 - $468,020
8,208 New
8,208 $461,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Pensionmark Financial Group, LLC Portfolio

Follow Pensionmark Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pensionmark Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pensionmark Financial Group, LLC with notifications on news.